T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity

doi:10.1084/jem.182.4.1029

This Article

	Full Text (PDF, 805K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Levey, D. L.
	Articles by Srivastava, P. K.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Levey, D. L.
	Articles by Srivastava, P. K.


Social Bookmarking

	What's this?

ARTICLES

T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity

DL Levey and PK Srivastava
Department of Biological Sciences, Fordham University, Bronx, New York 10458, USA.

Loss of T cell-associated signal transduction molecules has recently been implicated in immune suppression in tumor-bearing hosts. In the present study, we have examined this and related phenomenon extensively in a large number of tumor-bearing mice, analyzed individually. Splenic T cells from tumor-bearing mice were isolated and characterized with respect to the following: (a) levels of three tyrosine kinases, p56lck, p59fyn, and ZAP-70; (b) expression of CD3-zeta; (c) alloreactive responses; and (d) antigen-specific responses. Contrary to recent reports, T cells from tumor-bearing mice were observed to express normal levels of lck, fyn, ZAP-70, and CD3-zeta. Further, T cells showed healthy alloreactive and antigen-specific responses until approximately 3 wk after post tumor challenge, when the tumors constituted approximately 20% of the body weight. Alterations with respect to some parameters were observed only in mice that had been bearing larger tumors for a considerably longer period. As human tumors are unlikely to grow to such large sizes (e.g., > 20% of the total body weight), the significance of the alterations in T cell expression of lck, fyn, ZAP-70, or CD3-zeta in the immune status of cancer patients is unclear. Altogether, these results indicate that alterations in T cell signal transduction molecules do not account for the profound tumor-specific suppression observed during tumor growth.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Willimsky, G., Czeh, M., Loddenkemper, C., Gellermann, J., Schmidt, K., Wust, P., Stein, H., Blankenstein, T. (2008). Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness. JEM 205: 1687-1700 [Abstract] [Full Text]
Stewart, T. J., Abrams, S. I. (2007). Altered Immune Function during Long-Term Host-Tumor Interactions Can Be Modulated to Retard Autochthonous Neoplastic Growth. J. Immunol. 179: 2851-2859 [Abstract] [Full Text]
Kurt, R. A., Park, J. A., Schluter, S. F., Marchalonis, J. J., Akporiaye, E. T. (2000). TCR V{beta} usage and clonality of T cells isolated from progressing and rejected tumor sites before and after in vitro culture. Int Immunol 12: 639-646 [Abstract] [Full Text]
Radoja, S., Rao, T. D., Hillman, D., Frey, A. B. (2000). Mice Bearing Late-Stage Tumors Have Normal Functional Systemic T Cell Responses In Vitro and In Vivo. J. Immunol. 164: 2619-2628 [Abstract] [Full Text]
Maccalli, C., Pisarra, P., Vegetti, C., Sensi, M., Parmiani, G., Anichini, A. (1999). Differential Loss of T Cell Signaling Molecules in Metastatic Melanoma Patients' T Lymphocyte Subsets Expressing Distinct TCR Variable Regions. J. Immunol. 163: 6912-6923 [Abstract] [Full Text]
Horiguchi, S., Petersson, M., Nakazawa, T., Kanda, M., Zea, A. H., Ochoa, A. C., Kiessling, R. (1999). Primary Chemically Induced Tumors Induce Profound Immunosuppression Concomitant with Apoptosis and Alterations in Signal Transduction in T Cells and NK Cells. Cancer Res. 59: 2950-2956 [Abstract] [Full Text]
Gastman, B. R., Johnson, D. E., Whiteside, T. L., Rabinowich, H. (1999). Caspase-mediated Degradation of T-Cell Receptor {{zeta}}-Chain. Cancer Res. 59: 1422-1427 [Abstract] [Full Text]
Kuss, I., Saito, T., Johnson, J. T., Whiteside, T. L. (1999). Clinical Significance of Decreased {{zeta}} Chain Expression in Peripheral Blood Lymphocytes of Patients with Head and Neck Cancer. Clin. Cancer Res. 5: 329-334 [Abstract] [Full Text]
Schultze, J. L., Seamon, M. J., Michalak, S., Gribben, J. G., Nadler, L. M. (1997). Autologous Tumor Infiltrating T Cells Cytotoxic for Follicular Lymphoma Cells Can Be Expanded In Vitro. Blood 89: 3806-3816 [Abstract] [Full Text]
Guarini, A., Riera, L., Cignetti, A., Montacchini, L., Massaia, M., Foa, R. (1997). Transfer of the Interleukin-2 Gene Into Human Cancer Cells Induces Specific Antitumor Recognition and Restores the Expression of CD3/T-Cell Receptor Associated Signal Transduction Molecules. Blood 89: 212-218 [Abstract] [Full Text]
Otsuji, M., Kimura, Y., Aoe, T., Okamoto, Y., Saito, T. (1996). Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta �chain of T-cell receptor complex and antigen-specific�T-cell�responses. Proc. Natl. Acad. Sci. USA 93: 13119-13124 [Abstract] [Full Text]